ArticleFrontiers in immunology2026
Is it possible to use complete blood collection based systemic inflammatory indices as potential biomarkers for chronic spontaneous urticaria.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sleep quality, disturbance and the prevalence of obstructive sleep apnoea in chronic spontaneous urticaria and associated risk factors.The World Allergy Organization journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic spontaneous urticaria (CSU) is mediated not only by mast cells but also by eosinophils and basophils. We evaluated whether complete blood collection based systemic inflammatory indices- including the systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), aggregate Index of Systemic Inflammation (AISI), systemic inflammation modulation index (SIMI), neutrophil-to-lymphocyte ratio (NLR), eosinophil-to-lymphocyte ratio (ELR), platelet-to-lymphocyte ratio (PLR), basophil-to-lymphocyte ratio (BLR)-and platelet parameters (mean platelet volume [MPV], platelet distribution width [PDW], platelet large cell ratio [PLCR]) reflect CSU severity or treatment response. A retrospective study of 190 CSU patients and 570 matched controls was performed, with sensitivity analyses using propensity-score matching (PSM) and inverse-probability-of-treatment weighting (IPTW). Subgroup analyses examined UAS7, antihistamine response and allergy history. As a result, CSU patients exhibited lower SII/SIRI, white blood cells (WBC), neutrophils, lymphocytes, and NLR, alongside higher MPV/PLCR and reduced PDW. NLR showed a weak correlation with UAS7, and systemic indices did not reliably differentiate standard-dosed and updosed antihistamine response. Patients with allergy history demonstrated lower eosinophils and ELR. CSU is characterized by reduced systemic inflammatory indices and enhanced platelet activation. Among these, NLR may serve as a cost-effective supplementary tool for assessing systemic inflammation trends of CSU.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.